Clinical Trial Update: Investigation the Effect of Montelukast in COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of montelukast in COVID-19 is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Bahçeşehir University | Conditions: COVID-19, SARS-CoV-2 | Phase 2 | Status: UNKNOWN